SC 13D 1 renovatio_13d-031506.txt ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------ SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 HUMAN PHEROMONE SCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 44485Q203 (CUSIP Number) RENOVATIO GLOBAL FUNDS, L.P. 2221 OLD OAKLAND ROAD, SAN JOSE, CA 95131 (408) 456-0982 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) MARCH 10, 2006 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ]. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ================================================================================ CUSIP No. 44485Q203 -------------------------------------------------------------------------------- 1. Name of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Renovatio Global Funds, L.P. - 20-3889119 -------------------------------------------------------------------------------- 2. Check the Appropriate Box If a Member of a Group (See Instructions) (a) [_] (b) [_] -------------------------------------------------------------------------------- 3. SEC Use Only -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) OO -------------------------------------------------------------------------------- 5. Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [_] -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization California -------------------------------------------------------------------------------- 7. Sole Voting Power NUMBER OF 657,723 SHARES ----------------------------------------------------------------- BENEFICIALLY 8. Shared Voting Power OWNED BY None EACH ----------------------------------------------------------------- REPORTING 9. Sole Dispositive Power PERSON 657,723 WITH ----------------------------------------------------------------- 10. Shared Dispositive Power None -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 657,723 -------------------------------------------------------------------------------- 12. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [_] -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 15.8% -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) Limited Partnership -------------------------------------------------------------------------------- ITEM 1. SECURITY AND ISSUER The title of the class of equity securities to which this statement relates is Common Stock ("Issuer Common Stock") of Human Pheromone Sciences, Inc., a California corporation (the "Issuer"). The principal executive offices of the Issuer are located at 84 West Santa Clara Street, Suite 720, San Jose, CA 95113. ITEM 2. IDENTITY AND BACKGROUND. (a) The name of the entity filing this statement is Renovatio Global Funds, L.P., hereinafter sometimes referred to as the "Reporting Person." (b) The principal business address and the principal office of the Reporting Person is: 2221 Old Oakland Road, San Jose, CA 95113. (c) The Reporting Person's principal occupation or employment is investment, with a business address at 2221 Old Oakland Road, San Jose, CA 95113. (d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, United States Federal or State securities laws or finding any violations with respect to such laws. (f) United States of America ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The Reporting Person acquired 657,723 shares of Issuer Common Stock on March 10, 2006 for an aggregate consideration of $328,861.50 in cash. ITEM 4. PURPOSE OF TRANSACTION. The Reporting Person acquired the Issuer Common Stock held by it for investment purposes in connection with the Agreement described in Item 3. Except as described in this Item 4, the Reporting Person has no plans or proposals that would result in any of the transactions described in items (a) through (j) of Item 4 of Schedule 13D. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) See Rows 11 and 13 of the Cover Page. (b) See Rows 7 through 10 of the Cover Page. (c) During the past sixty days, the only transactions by the Reporting Person involving the Issuer's Common Stock are described in Item 3 above. (d) To the best knowledge of the Reporting Person, no other person has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, the shares of Issuer Common Stock reported in Item 5(a). (e) Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. The information set forth in Items 3 and 4 of this Schedule 13D is incorporated herein by reference. ITEM 7. MATERIALS TO BE FILED AS EXHIBITS. None. ================================================================================ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. REPORTING PERSON: RENOVATIO GLOBAL FUNDS, L.P. Date: March 14, 2006 By: /s/ Steven Yao --------------------------------- Name: Steven Yao, CFO of Dubuglo, LLC General Partner